RT Journal Article
SR Electronic
T1 Application of Optimal Control to the Dynamics of COVID-19 Disease in South Africa
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.08.10.20172049
DO 10.1101/2020.08.10.20172049
A1 Gatyeni, S. P.
A1 Chukwu, C.W.
A1 Chirove, F.
A1 Fatmawati
A1 Nyabadza, F.
YR 2021
UL http://medrxiv.org/content/early/2021/02/21/2020.08.10.20172049.abstract
AB SARS-CoV-2 (COVID-19) belongs to the beta-coronavirus family, which include: the severe acute respiratory syndrome coronavirus (SARS-CoV) and the Middle East respiratory syndrome coronavirus (MERS-CoV). Since its outbreak in South Africa in March 2020, it has lead to high mortality and thousands of people contracting the virus. Mathematical analysis of a model without controls was done and the basic reproduction number (ℛ0) of the COVID-19 for the South African pandemic determined. We introduced permissible controls and formulate an optimal control problem using the Pontraygain Maximum Principle. Our numerical findings suggest that joint implementation of effective mask usage, physical distancing and active screening and testing, are effective measures to curtail the spread of the disease in the human population. The results obtained in this paper are of public health importance in the control and management of the spread for the novel coronavirus, SARS-CoV-2, in South Africa.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo fuundingAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:2255All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesCited in text